Analysis: Nath Bio-Genes (India) Limited

NSE:NATHBIOGEN Floriculture/Tissue Culture Market cap: ₹291 cr

Growth thesis

Nath Bio-Genes is an Indian hybrid seed company focused on cotton, paddy, maize, and non-cotton non-paddy (NCP) crops, with international operations in Uzbekistan. Cotton hybrids (Sanket/Jumbo) and paddy (25% YoY volume growth) form its core, while maize (54% YoY volume surge) and vegetable seeds (25% YoY value growth) drive diversification. Growth is fueled by next-gen cotton hybrids (2020-era pipeline), Uzbekistan JV expansion (targeting USD 100 million cotton market in Central Asia), and 15-20% FY27 revenue growth guidance. The business aims to scale international revenue to 10-15% of total sales by 2027-28 while maintaining EBITDA margin stability. Key execution risk: geopolitical/regulatory challenges in Central Asia and Africa as international operations scale.

Why is Nath Bio-Genes (India) Limited stock rising?

  • Revenue growth guidance of 15-20% for FY27 with slightly upward EBITDA and net profit margins
  • Cotton flagship hybrids Sanket and Jumbo expected to maintain production stability for the next 2-3 years
  • Maize volume expected to scale significantly with 3-4x growth target for products Dominator-401 and 1133 in FY27
  • Pipeline of new varieties across cotton, paddy, maize, vegetables and non-cotton non-paddy segment is robust and will be introduced commercially in coming seasons
  • International expansion: Uzbekistan JV revenue to be scaled, targeting 10-15% of total revenue from international operations over 3-5 years

Research report

companyname: Nath Bio-Genes (India) Limited ticker: NATHBIOGEN sector: Seed Industry / Agriculture Nath Bio-Genes (India) Limited is a seed company that produces, processes, and markets hybrid and genetically modified seeds for field crops, vegetables, and plant nutrients. Incorporated in 1993, the company operates three processing plants in Aurangabad and Nizamabad, and distributes through a pan-India network of over 20,000 distributors. It also has a joint venture in Uzbekistan and is explori...

Read the full report →

Catalysts

margin expansion, geographic expansion

Growth guidance

FY27 revenue growth guided at 15-20% driven by 20% cotton, 20-25% paddy, and high-growth maize; EBITDA margin to trend upward

Guidance upgraded
RS rating: 34 Stage: Stage 3

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Nath Bio-Genes (India) Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.
More in Floriculture/Tissue Culture